Antimalarial drugs could support existing cancer treatments
Chloroquine and hydroxychloroquine could make cancer treatments more effective...
List view / Grid view
Chloroquine and hydroxychloroquine could make cancer treatments more effective...
Cell-weighing technique may predict which therapies a patient is most sensitive or resistant to...
In vitro study verifies method for remotely triggering release of cancer drugs...
A study has shown that Adipocytes can absorb and metabolise the chemotherapeutic agent daunorubicin, reducing its ability to kill cancer cells.
A study has provided strong evidence that certain carbon nanotubes used in manufacturing could pose the same cancer risk as asbestos...
The long-term use of proton pump inhibitors, a class of drugs commonly used to treat acid reflux, is linked to the risk of developing stomach cancer...
Sandoz has announced that its biosimilar pegfilgrastim has been accepted by the EMA for regulatory review...
The FDA has approved Yescarta, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma...
The NIH and 11 leading biopharmaceutical companies have launched the Partnership for Accelerating Cancer Therapies (PACT), totalling $215m as part of the Cancer Moonshot....
Scientists have used genome sequencing to gain a better understanding of the biology underlying chordoma...
Breast cancer drug neratinib has been found to block the function of the Ras genes which are among the first to be linked to cancer development...
TLR agonists injected directly into a tumour suppresses tumour growth throughout the whole body...
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
Immune-cell based therapies opening a new frontier for cancer treatment carry unique, potentially lethal side effects...
Painful side effects from cancer medicines could be tackled with a drug that eases the effects of jetlag...